Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Natera (NTRA)
NASDAQ:NTRA
Holding NTRA?
Track your performance easily
NTRA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$59.80 - $177.00
Previous CloseN/A
Volume352.74K
Average Volume (3M)1.09M
Market Cap
$23.10B
Enterprise Value$15.27B
Total Cash (Recent Filing)$146.12M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Feb 26, 2025EPS Estimate
-0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.77
Shares Outstanding132,020,810
10 Day Avg. Volume1,019,833
30 Day Avg. Volume1,088,254
Standard Deviation0.16
R-Squared0.28
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)15.08
Price to Cash Flow (P/CF)111.50
P/FCF Ratio149.30
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue9.97
Enterprise Value/Gross Profit30.98
Enterprise Value/Ebitda-150.15
Forecast
1Y Price Target
$185.08Price Target Upside5.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Natera News
Ownership Overview
4.87% Insiders
26.54% Mutual Funds
0.03% Other Institutional Investors
54.56% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NTRA FAQ
What was Natera’s price range in the past 12 months?
Natera lowest stock price was $59.80 and its highest was $177.00 in the past 12 months.
What is Natera’s market cap?
Natera’s market cap is $23.10B.
When is Natera’s upcoming earnings report date?
Natera’s upcoming earnings report date is Feb 26, 2025 which is in 44 days.
How were Natera’s earnings last quarter?
Natera released its earnings results on Nov 12, 2024. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.575 by $0.315.
Is Natera overvalued?
According to Wall Street analysts Natera’s price is currently Undervalued.
Does Natera pay dividends?
Natera does not currently pay dividends.
What is Natera’s EPS estimate?
Natera’s EPS estimate is -0.5.
How many shares outstanding does Natera have?
Natera has 132,020,810 shares outstanding.
What happened to Natera’s price movement after its last earnings report?
Natera reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.575. Following the earnings report the stock price went up 19.131%.
Which hedge fund is a major shareholder of Natera?
Among the largest hedge funds holding Natera’s share is Farallon Capital Management, L.L.C.. It holds Natera’s shares valued at 579M.
---
Natera Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$185.08 (5.76% Upside)
$185.08 (5.76% Upside)
Blogger Sentiment
Bullish
NTRA Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $17.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
173.90%
12-Months-Change
Fundamentals
Return on Equity
-25.82%
Trailing 12-Months
Asset Growth
9.98%
Trailing 12-Months
Company Description
Natera
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
---
NTRA Company Deck
---
NTRA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Natera's strong financial and operational performance, with record revenue growth, increased oncology test volumes, and significant clinical data achievements. While there were some challenges related to weather impacts and litigation expenses, the overall outlook remains positive with raised guidance and strong cash flow generation.Read More>---
NTRA Stock 12 Month Forecast
Average Price Target
$185.08
▲(5.76% Upside)
Technical Analysis
Guardant Health
―
Exact Sciences
―
Fulgent Genetics
―
QuidelOrtho
―
Myriad Genetics
―
Cue Biopharma
―
Best Analysts Covering NTRA
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+64.60%
assigned a buy rating 2 months ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +64.60% per trade.
---